Read by QxMD icon Read


Eduardo Collantes Estévez et al.
GRESSER (the Spondyloarthritis Study Group of SER) reunites, since 1999, Spanish rheumatologists interested in learning and disseminating knowledge on spondyloarthritis, and over the years has maintained an important scientific activity based on the development of various research projects (Regisponser and follow up cohorts: Early and EA, respondia, the ESPERANZA Program, etc.,) which has resulted in interesting scientific publications and high impact communications in national and international journals. However, and despite this production being very noticeable, Gresser has managed, above all, to draw attention to these diseases by Spanish rheumatologists and create an interesting field of study that offers new and young professionals, in one way or another, access to these intriguing conditions...
March 2012: Reumatología Clinica
Eduardo Puertas-Abreu, Elaudi Rodríguez Polanco, Miriam Azocar, Luis Antonio Mundarain, Concepción Morelia Nuñez-Sotelo, Rafael Montaño, Freddy Herrera Vivas, Zair Tovar Noguera, Francisco Marín, Omar Bellorin, José Gregorio Rivas, Eduardo Toro, Eugenia Benzaquen, Mayra Rauseo, Luis Arturo Gutiérrez González
BACKGROUND: The anti-TNFα therapy has been since its approval by the FDA, along with nonsteroidal antiinflammatory drugs (NSAIDs), one of the most important therapies for control of spondyloarthritis (SpA). The onset of Lupus Like Syndrome (LLS) has been described in patients with rheumatoid arthritis (RA) treated with anti-TNFα therapy but there is little literature on the occurrence of this entity in patients with SpA. METHODS: We studied 57 patients with SpA who received more than 1 year of anti-TNFα therapy (infliximab, adalimumab or etanercept)...
2012: International Archives of Medicine
Marena Rojas-Vargas, Elisa Muñoz-Gomariz, Alejandro Escudero, Pilar Font, Pedro Zarco, Raquel Almodovar, Jordi Gratacós, Juan Mulero, Xavier Juanola, Carlos Montilla, Estefanía Moreno, Eduardo Collantes-Estevez
OBJECTIVE: To determine the first signs and symptoms, and the clinical, biological and radiological characteristics of patients with early SpA. METHODS: A total of 150 SpA patients were selected from 2367 listed in REGISPONSER (Registro Español de Espondiloartritis de la Sociedad Española de Reumatología). The inclusion criterion was a disease course of <or=2 yrs from the onset of symptoms or the appearance of the first sign of disease. RESULTS: Forty-six patients had AS, 51 psoriatic SpA (Ps-SpA), 43 uSpA, 5 ReA, 4 IBD arthropathy and 1 JCA...
April 2009: Rheumatology
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"